4.0 Editorial Material

Mobile phone-based interventions for smoking cessation

Journal

SAO PAULO MEDICAL JOURNAL
Volume 128, Issue 2, Pages 106-107

Publisher

ASSOCIACAO PAULISTA MEDICINA
DOI: 10.1590/S1516-31802010000200014

Keywords

-

Ask authors/readers for more resources

BACKGROUND: Innovative effective smoking cessation interventions are required to appeal to those who are not accessing traditional cessation services. Mobile phones are widely used and are now well integrated into the daily lives of many, particularly young adults. Mobile phones are a potential medium for the delivery of health programmes such as smoking cessation. OBJECTIVES: To determine whether mobile phone-based interventions are effective at helping people who smoke, to quit. SEARCH STRATEGY: We searched MEDLINE, EMBASE, Cinahl, PsycINFO,The Cochrane Library, the National Research Register and the Clinical Trials register, with no restrictions placed on language or publication date. SELECTION CRITERIA: We included randomized or quasi-randomized trials. Participants were smokers of any age who wanted to quit. Studies were those examining any type of mobile phone-based intervention. This included any intervention aimed at mobile phone users, based around delivery via mobile phone, and using any functions or applications that can be used or sent via a mobile phone. DATA COLLECTION AND ANALYSIS: Information on the specified quality criteria and methodological details was extracted using a standardised form. Participants who dropped out of the trials or were lost to follow up were considered to be smoking. Meta-analysis of the included studies was undertaken using the Mantel-Haenszel Risk Ratio fixed-effect method provided that there was no evidence of substantial statistical heterogeneity as assessed by the 12 statistic. Where meta-analysis was not possible, summary and descriptive statistics are presented. MAIN RESULTS: Four studies were excluded as they were small non-randomized feasibility studies, and two studies were excluded because follow up was less than six months. Four trials (reported in five papers) are included: a text message programme in New Zealand; a text message programme in the UK; and an Internet and mobile phone programme involving two different groups in Norway. The different types of interventions are analysed separately. When combined by meta-analysis the text message programme trials showed a significant increase in short-term self-reported quitting (RR 2.18, 95% CI 1.80 to 2.65). However, there was considerable heterogeneity in long-term outcomes, with the much larger trial having problems with misclassification of outcomes; therefore these data were not combined. When the data from the Internet and mobile phone programmes were pooled we found statistically significant increases in both short and long-term self-reported quitting (RR 2.03, 95% CI 1.40 to 2.94). AUTHORS' CONCLUSIONS: The current evidence shows no effect of mobile phone-based smoking cessation interventions on long-term outcome. While short-term results are positive, more rigorous studies of the long-term effects of mobile phone-based smoking cessation interventions are needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Substance Abuse

Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders

Saki Rubaiya Talukder, Julia M. Lappin, Veronica Boland, Hayden McRobbie, Ryan James Courtney

Summary: Smokers with mental health disorders are under-represented in clinical trials evaluating smoking cessation medications, emphasizing the need to increase their participation to address accessibility issues for this vulnerable population.

TOBACCO CONTROL (2023)

Article Education, Special

Knowledge, Attitudes, and Practices Towards Fetal Alcohol Spectrum Disorder in New Zealand Educators: An Online Survey

Joanna Ting Wai Chu, Jessica C. McCormack, Samantha Marsh, Chris Bullen

Summary: This study examines the knowledge, attitudes, awareness, and practices of education professionals in Aotearoa New Zealand regarding Fetal Alcohol Spectrum Disorder (FASD). The findings highlight the gaps in knowledge and emphasize the need to support individuals with FASD in educational settings.

JOURNAL OF INTELLECTUAL DISABILITIES (2023)

Article Urology & Nephrology

Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality Results from a Randomized Controlled Trial of ACE Inhibitors

Toshiaki Ohkuma, Katie Harris, Mark Cooper, Diederick E. Grobbee, Pavel Hamet, Stephen Harrap, Giuseppe Mancia, Michel Marre, Anushka Patel, Anthony Rodgers, Bryan Williams, Mark Woodward, John Chalmers

Summary: The occurrence of hyperkalemia during ACEI treatment was 6%, and randomized treatment with ACEI significantly reduced the risk of major macrovascular and microvascular events, regardless of the short-term changes in serum potassium levels during the trial period.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Article Substance Abuse

Biomarkers of potential harm in people switching from smoking tobacco to exclusive e-cigarette use, dual use or abstinence: secondary analysis of Cochrane systematic review of trials of e-cigarettes for smoking cessation

Jamie Hartmann-Boyce, Ailsa R. Butler, Annika Theodoulou, Igho J. Onakpoya, Peter Hajek, Chris Bullen, Nancy A. Rigotti, Nicola Lindson

Summary: This study compares biomarkers of potential harm among different groups of individuals based on their behavior in electronic cigarette intervention studies. The findings suggest that switching from smoking to vaping or dual use can significantly reduce levels of biomarkers of potential harm.

ADDICTION (2023)

Article Peripheral Vascular Disease

Reduced efficacy of blood pressure lowering drugs in the presence of diabetes mellitus-results from the TRIUMPH randomised controlled trial

Sonali R. Gnanenthiran, Ruth Webster, Asita de Silva, Pallab K. Maulik, Abdul Salam, Vanessa Selak, Rama K. Guggilla, Aletta E. Schutte, Anushka Patel, Anthony Rodgers

Summary: The study found that patients with diabetes mellitus had reduced efficacy of blood pressure lowering therapies compared to patients without diabetes, regardless of the type of blood pressure lowering therapy received.

HYPERTENSION RESEARCH (2023)

Article Peripheral Vascular Disease

Clinical Utility of Short-Term Blood Pressure Measures to Inform Long-Term Blood Pressure Management

Nelson Wang, Katie Harris, Mark Woodward, Stephen Harrap, Giuseppe Mancia, Neil Poulter, John Chalmers, Anthony Rodgers

Summary: The utility of short-term blood pressure changes in determining long-term treatment response was assessed in two randomized trials, and it was found that changes in blood pressure immediately after starting treatment did not significantly affect subsequent treatment response.

HYPERTENSION (2023)

Article Peripheral Vascular Disease

The Proportion of Dietary Salt Replaced With Potassium-Enriched Salt in the SSaSS: Implications for Scale-Up

Xuejun Yin, Ellie Paige, Maoyi Tian, Qiang Li, Liping Huang, Jie Yu, Anthony Rodgers, Paul Elliott, Yangfeng Wu, Bruce Neal

Summary: The SSaSS study found that potassium-enriched salt can have definitive effects on cardiovascular outcomes and death. By quantifying the amount of potassium-enriched salt used, researchers were able to estimate the impact on risk reduction and the potential for population-wide scale-up. The results showed that even a partial replacement of regular salt with potassium-enriched salt can deliver significant health gains.

HYPERTENSION (2023)

Article Health Care Sciences & Services

Effectiveness of a Sodium-Reduction Smartphone App and Reduced-Sodium Salt to Lower Sodium Intake in Adults With Hypertension: Findings From the Salt Alternatives Randomized Controlled Trial

Helen Eyles, Jacqueline Grey, Yannan Jiang, Elaine Umali, Rachael McLean, Lisa Te Morenga, Bruce Neal, Anthony Rodgers, Robert N. Doughty, Cliona Ni Mhurchu

Summary: The study aimed to determine whether a 12-week intervention with a sodium-reduction package comprising the SaltSwitch smartphone app and reduced-sodium salts could reduce urinary sodium excretion in adults with high blood pressure. However, the study found no evidence that dietary sodium intake was reduced in adults with high blood pressure. This may be due to lower engagement with the trial intervention package by participants.

JMIR MHEALTH AND UHEALTH (2023)

Review Clinical Neurology

The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis

Cheryl Carcel, Faraidoon Haghdoost, Joanne Shen, Puneet Nanda, Yu Bai, Emily Atkins, Takako Torii-Yoshimura, Alexander J. Clough, Leo Davies, Dennis Cordato, Lyn R. Griffiths, Grace Balicki, Xia Wang, Kota Vidyasagar, Alejandra Malavera, Craig S. Anderson, Alessandro S. Zagami, Candice Delcourt, Anthony Rodgers

Summary: Currently, only a few specific blood pressure-lowering medications are recommended for migraine prevention. However, a broader range of blood pressure-lowering medications and drugs have been found to effectively reduce the frequency of migraine attacks.

CEPHALALGIA (2023)

Article Peripheral Vascular Disease

Evaluation of the ability of a commercially available cuffless wearable device to track blood pressure changes

Isabella Tan, Sonali R. Gnanenthiran, Justine Chan, Konstantinos G. Kyriakoulis, Markus P. Schlaich, Anthony Rodgers, George S. Stergiou, Aletta E. Schutte

Summary: This study investigated the accuracy of a commercially available cuffless wearable blood pressure device in tracking blood pressure changes. The results showed that compared to conventional monitoring methods, the device reported higher values for 24-hour and nighttime systolic and diastolic blood pressure, and it was unable to accurately track medication-induced blood pressure changes.

JOURNAL OF HYPERTENSION (2023)

Review Cardiac & Cardiovascular Systems

Efficacy and Safety of Low-Dose Triple and Quadruple Combination Pills vs Monotherapy, Usual Care, or Placebo for the Initial Management of Hypertension A Systematic Review and Meta-analysis

Nelson Wang, Phidias Rueter, Emily Atkins, Ruth Webster, Mark Huffman, Asita de Silva, Clara Chow, Anushka Patel, Anthony Rodgers

Summary: Low-dose combination (LDC) antihypertensives consisting of 3 or 4 blood pressure-lowering drugs have shown to be an effective and well-tolerated treatment option for initial management of hypertension. LDC therapy resulted in greater reduction in systolic blood pressure and higher proportion of patients achieving target blood pressure compared to monotherapy or placebo. The findings support the importance of considering LDC therapy for hypertension management.

JAMA CARDIOLOGY (2023)

Article Medicine, General & Internal

Can old drugs learn new tricks? Achieving registration and public subsidy listing for off-patent medicines with novel therapeutic applications

Jonathan Brett, Dilara Bahceci, Wendy Lipworth, Paul Liknaitzky, Ric O. Day, Anthony Rodgers

Summary: With the rising costs of drug development, the reutilization of low-cost medicines for new indications is becoming increasingly important. However, there are various obstacles to repurposing, especially for off-patent medicines, and limited motivation for the pharmaceutical industry to sponsor registration and public subsidy listing. In this article, we examine these barriers and their implications, and present successful examples of repurposing strategies.

INTERNAL MEDICINE JOURNAL (2023)

Review Medicine, General & Internal

Ketamine for the treatment of major depression: a systematic review and meta-analysis

Stevan Nikolin, Anthony Rodgers, Andreas Schwaab, Anees Bahji, Carlos Zarate, Gustavo Vazquez, Colleen Loo

Summary: This systematic review and meta-analysis found that racemic ketamine was more effective than esketamine in treating depression. Higher doses of ketamine were more effective than lower doses. There were differences in the initial effects, ongoing treatment, and lasting effects after the treatment course.

ECLINICALMEDICINE (2023)

Article Peripheral Vascular Disease

Wisdom of the Crowd: insights gained from comparing predicted and observed effects of blood pressure lowering strategies

Sonali R. Gnanenthiran, Vivekanand Jha, Abdul Salam, Emily Atkins, Clara K. Chow, Mark R. Nelson, Mike Rakotz, Markus P. Schlaich, Aletta E. Schutte, Tim Usherwood, Anthony Rodgers

Summary: In this study, we assessed whether pooled cardiovascular expertise could accurately predict the efficacy and tolerability of both a novel and an established treatment option. A survey was conducted to collect predictions of blood pressure at 12 weeks and 52 weeks for participants in a trial called QUARTET, which involved two different treatment groups.

JOURNAL OF HUMAN HYPERTENSION (2023)

Article Peripheral Vascular Disease

Cost-effectiveness analysis of initial treatment with single-pill combination antihypertensive medications

Alexis S. Bryan, Andrew E. Moran, Claire M. Mobley, Catherine G. Derington, Anthony Rodgers, Yiyi Zhang, Valy Fontil, Steven Shea, Brandon K. Bellows

Summary: Hypertension guidelines recommend initiating treatment with single pill combination (SPC) antihypertensive medications, but only one-third of treated hypertensive US adults use SPCs. This analysis evaluated the cost-effectiveness of initial treatment with SPC dual antihypertensive medications compared to usual care monotherapy in hypertensive US adults. The results showed that initiating antihypertensive treatment with SPC dual therapy can provide more QALYs without additional cost compared to usual care monotherapy.

JOURNAL OF HUMAN HYPERTENSION (2023)

No Data Available